579 related articles for article (PubMed ID: 29908120)
21. The effect of altered sphingolipid acyl chain length on various disease models.
Park WJ; Park JW
Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
[TBL] [Abstract][Full Text] [Related]
22. "Fix and Click" for Assay of Sphingolipid Signaling in Single Primary Human Intestinal Epithelial Cells.
Gallion LA; Wang Y; Massaro A; Yao M; Petersen BV; Zhang Q; Huang W; Carr AJ; Zhang Q; Allbritton NL
Anal Chem; 2022 Jan; 94(3):1594-1600. PubMed ID: 35020354
[TBL] [Abstract][Full Text] [Related]
23. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
25. The clinical potential of sphingolipid-based therapeutics.
Fox TE; Finnegan CM; Blumenthal R; Kester M
Cell Mol Life Sci; 2006 May; 63(9):1017-23. PubMed ID: 16568241
[TBL] [Abstract][Full Text] [Related]
26. The use of click chemistry in sphingolipid research.
Jamecna D; Höglinger D
J Cell Sci; 2024 Mar; 137(6):. PubMed ID: 38488070
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of sphingolipid metabolism in plasma, hippocampus, and cerebral cortex of mice administered sphingolipid modulating agents.
Giles C; Takechi R; Mellett NA; Meikle PJ; Dhaliwal S; Mamo JC
J Neurochem; 2017 May; 141(3):413-422. PubMed ID: 28129448
[TBL] [Abstract][Full Text] [Related]
28. Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.
Ung J; Tan SF; Fox TE; Shaw JJP; Vass LR; Costa-Pinheiro P; Garrett-Bakelman FE; Keng MK; Sharma A; Claxton DF; Levine RL; Tallman MS; Cabot MC; Kester M; Feith DJ; Loughran TP
Blood Rev; 2022 Sep; 55():100950. PubMed ID: 35487785
[TBL] [Abstract][Full Text] [Related]
29. Bi- and Trifunctional Lipids for Visualization of Sphingolipid Dynamics within the Cell.
Höglinger D
Methods Mol Biol; 2019; 1949():95-103. PubMed ID: 30790251
[TBL] [Abstract][Full Text] [Related]
30. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
31. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
32. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of a polyyne-containing sphingoid base probe as a chemical tool.
Lee YM; Lim C; Lee HS; Shin YK; Shin KO; Lee YM; Kim S
Bioconjug Chem; 2013 Aug; 24(8):1324-31. PubMed ID: 23926922
[TBL] [Abstract][Full Text] [Related]
34. Use of N-([1-14C]hexanoyl)-D-erythro-sphingolipids to assay sphingolipid metabolism.
Futerman AH; Pagano RE
Methods Enzymol; 1992; 209():437-46. PubMed ID: 1495424
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
[TBL] [Abstract][Full Text] [Related]
36. Azide-tagged sphingolipids: new tools for metabolic flux analysis.
Garrido M; Abad JL; Fabriàs G; Casas J; Delgado A
Chembiochem; 2015 Mar; 16(4):641-50. PubMed ID: 25676480
[TBL] [Abstract][Full Text] [Related]
37. Fluorescently Labeled Ceramides and 1-Deoxyceramides: Synthesis, Characterization, and Cellular Distribution Studies.
Izquierdo E; López-Corrales M; Abad-Montero D; Rovira A; Fabriàs G; Bosch M; Abad JL; Marchán V
J Org Chem; 2022 Dec; 87(24):16351-16367. PubMed ID: 36441972
[TBL] [Abstract][Full Text] [Related]
38. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
39. Stereoselective preparation of quaternary 2-vinyl sphingosines and ceramides and their effect on basal sphingolipid metabolism.
Calderón R; Mercadal N; Abad JL; Ariza X; Delgado A; Garcia J; Rodríguez A; Fabriàs G
Chem Phys Lipids; 2017 Jun; 205():34-41. PubMed ID: 28445710
[TBL] [Abstract][Full Text] [Related]
40. Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death.
Mullen TD; Obeid LM
Anticancer Agents Med Chem; 2012 May; 12(4):340-63. PubMed ID: 21707511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
